Two Federal Trade Commission lawyers should be shielded from claims they improperly retaliated against an Atlanta-based medical testing company whose chief executive publicly criticized the agency, a Washington federal appeals court ruled Friday.

The decision, by a three-judge panel of the U.S. Court of Appeals for the D.C. Circuit, overturned an earlier ruling that allowed the now-defunct LabMD and its chief executive, Michael Daugherty, to pursue First Amendment claims against FTC attorneys Alain Sheer and Ruth Yodaiken.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]